A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: A California Cancer Consortium study

Primo N Lara, Jeff Longmate, Christopher P Evans, David I. Quinn, Przemyslaw Twardowski, Gurkamal Chatta, Edwin Posadas, Walter Stadler, David R Gandara

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: A California Cancer Consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences